Skip to main content
SpringerLink
Log in
Book cover

Osteoporosis Research pp 135–157Cite as

Nonhuman Primate Models of Osteoporosis

  • Chapter
  • First Online:

Abstract

This chapter reviews the use of the nonhuman primate (NHP) as an animal model for osteoporosis research. While the previous chapters have extensively covered the use of lower species, the use of a higher species such as the NHP is likely to be the ultimate, or in some cases, the only relevant species to study bone in osteoporosis research. NHPs are used extensively in osteoporosis research in the pharmaceutical industry to evaluate new drug targets and in this context have contributed much to our current understanding of the human disease. This chapter focuses on the use of the NHP in drug development, presenting practical information on model selection and current techniques used to derive the primary end points of interest. Most of the practices described are considered relevant even in a basic research laboratory setting and will hopefully prove useful to researchers outside the pharmaceutical industry.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Reinwald S, Burr D. Review of nonprimate, large animal models for osteoporosis research. J Bone Miner Res. 2008; 23(9):1353-1368.

    Article  PubMed  Google Scholar 

  2. Brommage R. Perspectives on using nonhuman primates to understand the etiology and treatment of postmenopausal osteoporosis. J Musculoskelet Neuronal Interact. 2001;1(4): 307-325.

    PubMed  CAS  Google Scholar 

  3. Ominsky M, Vlasseros F, Jolette J, et al. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res. 2010,25(5):948-959 (E-Pub January 8, 2010).

    Article  Google Scholar 

  4. Smith SY, Recker RR, Hannan M, et al. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone. 2003;32(1):45-55.

    Article  PubMed  CAS  Google Scholar 

  5. Smith BB, Cosenza ME, Mancini A, et al. A toxicity profile of osteoprotegerin in the cynomolgus monkey. Int J Toxicol. 2003;22(5):403-412.

    PubMed  CAS  Google Scholar 

  6. Stroup GB, Hoffman SJ, Vasko-Moser JA, et al. Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: a short-term model for evaluation of antiresorptive therapy. Bone. 2001;28:532-537.

    Article  PubMed  CAS  Google Scholar 

  7. FDA. Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. In: Products DoMaED, ed. Rockville: Food and Drug Administration; 1994.

    Google Scholar 

  8. CHMP. Guideline on the Evaluation of Medicinal Products in the Treatment of Primary Osteoporosis. London: European Medicines Agency; 2006.

    Google Scholar 

  9. JMHW. Guideline concerning the clinical evaluation method for Anti-Osteoporosis agents, pharmaceutical examination No. 742. In: Management BoH, ed.: issued by the Prefecural Bureau Chief, Bureau of Health Management, Section of Examination and Control, Bureau of Drug Safety, Japanese Ministry of Health and Welfare, 1999.

    Google Scholar 

  10. Jayo M, Jerome C, Lees C, et al. Bone mass in female cynomolgus macaques: a cross-sectional and longitudinal study by age. Calcif Tissue Int. 1994;54(3):231-236.

    Article  PubMed  CAS  Google Scholar 

  11. Champ J, Binkley N, Havighurst T, et al. The effect of advancing age on bone mineral content of female rhesus monkeys. Bone. 1996;19(5):485-492.

    Article  PubMed  CAS  Google Scholar 

  12. Smith SY, Varela A. Effect of diet (phytoestrogens) on the ovariectomy response in the cynomolgus monkey model of osteoporosis. J Bone Miner Res 2009; 24 (Suppl 1), SU0404.

    Google Scholar 

  13. Balena R, Toolan B, Shea M, et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest. 1993; 92(6):2577-2586.

    Article  PubMed  CAS  Google Scholar 

  14. Jerome C, Turner C, Lees C. Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis). Calcif Tissue Int. 1997;60(3):265-270.

    Article  PubMed  CAS  Google Scholar 

  15. Jerome C. Primate models of osteoporosis. Lab Anim Sci. 1998;48(6):618-622.

    PubMed  CAS  Google Scholar 

  16. Binkley N, Kimmel D, Bruner J, et al. Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys. J Bone Miner Res. 1998; 13(11):1775-1782.

    Article  PubMed  CAS  Google Scholar 

  17. Brommage R, Hotchkiss C, Lees C, et al. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab. 1999;84(10):3757-3763.

    Article  PubMed  CAS  Google Scholar 

  18. Burr D, Hirano T, Turner C, et al. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res. 2001;16(1):157-165.

    Article  PubMed  CAS  Google Scholar 

  19. Jerome C, Peterson P. Nonhuman primate models in skeletal research. Bone. 2001;29(1):1-6.

    Article  PubMed  CAS  Google Scholar 

  20. Hotchkiss C, Stavisky R, Nowak J, et al. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys. Bone. 2001; 29(1):7-15.

    Article  PubMed  CAS  Google Scholar 

  21. Lees C, Register T, Turner C, et al. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys. Menopause. 2002;9(5):320-328.

    Article  PubMed  Google Scholar 

  22. Smith SY, Jolette J, Turner CH. Skeletal health: primate model of postmenopausal. Am J Primatol. 2009;71:1-14.

    Google Scholar 

  23. Fox J, Miller MA, Newman MK, et al. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine. J Bone Miner Res. 2007;22(2):260-273.

    Article  PubMed  CAS  Google Scholar 

  24. Russo CR, Lauretani F, Bandinelli S, et al. Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int. 2003;14(7):531-538.

    Article  PubMed  CAS  Google Scholar 

  25. Hotchkiss C. Use of peripheral quantitative computed tomography for densitometry of the femoral neck and spine in cynomolgus monkeys (Macaca fascicularis). Bone. 1999;24:101-107.

    Article  PubMed  CAS  Google Scholar 

  26. Dickerson S, Hotchkiss C. Relationships between densitometric and morphological parameters as measured by peripheral computed tomography and the compressive behavior of lumbar vertebral bodies from macaques (Macaca fascicularis). Spine. 2008;33(4):366-372.

    Article  PubMed  Google Scholar 

  27. Ahlborg H, Johnell O, Turner C, et al. Bone loss and bone size after menopause. N Engl J Med. 2003;349(4):327-334.

    Article  PubMed  Google Scholar 

  28. Burghardt A, Kazakia G, Ramachandran S, et al. Age and gender related differences in the geometric properties and biomechanical significance of intra-cortical porosity in the distal radius and tibia. J Bone Miner Res. 2009;25(5):983-993 (Accepted article online: December 14, 2009).

    Google Scholar 

  29. Kazakia G, Hyun B, Burghardt J, et al. In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and High-Field MR Imaging. J Bone Miner Res. 2008;23:463-474.

    Article  PubMed  Google Scholar 

  30. Parfitt A, Drezner M, Glorieux F, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 1987;2(6):595-610.

    Article  PubMed  CAS  Google Scholar 

  31. Fox J, Miller M, Newman M, et al. Effects of daily treatment with parathyroid hormone 1–84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Bone. 2007;41(3):321-330.

    Article  PubMed  CAS  Google Scholar 

  32. Turner C. Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int. 2002;13:97-104.

    Article  PubMed  CAS  Google Scholar 

  33. Turner C, Burr D. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14:595-608.

    Article  PubMed  CAS  Google Scholar 

  34. Burr D. Estimated intracortical bone turnover in the femur of growing macaques: implications for their use as models in skeletal pathology. Anat Rec. 1992;232(2):180-189.

    Article  PubMed  CAS  Google Scholar 

  35. Prestwood K, Gunness M, Muchmore D, et al. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. J Clin Endocrinol Metab. 2000;85(6): 2197-2202.

    Article  PubMed  CAS  Google Scholar 

  36. Lees C, Shen V, Brommage R. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys. Menopause. 2007;14(1):97-105.

    Article  PubMed  Google Scholar 

  37. Cline J, Botts S, Lees C, et al. Effects of lasofoxifene on the uterus, vagina, and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis). Am J Obstet Gynecol 2008;199:158.el-8.

    Google Scholar 

  38. Heringa M. Review on raloxifene: profile of a selective estrogen receptor modulator. Int J Clin Pharmacol Ther. 2003;41(8):331-345.

    PubMed  CAS  Google Scholar 

  39. Doyle N, Smith S, Veverka K. Male and female cynomolgus monkey models of osteoporosis: comparative in vivo data. J Bone Miner Res. 2008;23:S353.

    Google Scholar 

  40. Benhamou C. Effects of osteoporosis medications on bone quality. Joint Bone Spine. 2007;74(1):39-47.

    Article  PubMed  CAS  Google Scholar 

  41. Fox J, Miller M, Recker R, et al. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1–84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur. Calcif Tissue Int. 2007;81(1):53-63.

    Article  PubMed  CAS  Google Scholar 

  42. Fox J, Newman M, Turner C, et al. Effects of treatment with parathyroid hormone 1–84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys. Calcif Tissue Int. 2008;82(3):212-220.

    Article  PubMed  CAS  Google Scholar 

  43. Miller M, Bare S, Recker R, et al. Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1–84. Bone. 2008;42(6):1175-1183.

    Article  PubMed  CAS  Google Scholar 

  44. Recker R, Bare S, Smith S, et al. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84. Bone. 2009;44(1):113-119.

    Article  PubMed  CAS  Google Scholar 

  45. Gadeleta S, Boskey A, Paschalis E, et al. A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrlone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone. 2000;27(4):541-550.

    Article  PubMed  CAS  Google Scholar 

  46. Huang R, Miller L, Carlson C, et al. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrlone decanoate treatment. Bone. 2002;30(3):492-497.

    Article  PubMed  CAS  Google Scholar 

  47. Gourion-Arsiquaud S, Burket J, Havill L, et al. Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res. 2009;24(7):1271-1281.

    Article  PubMed  Google Scholar 

  48. Saito M. Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for eastimation of bone quality. Clin Calcium. 2009;19(8):1110-1117.

    PubMed  CAS  Google Scholar 

  49. Saito M, Fujii K, Mori Y, et al. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int. 2006;17(10):1514-1523.

    Article  PubMed  CAS  Google Scholar 

  50. Tami A, Nasser P, Verborgt O, et al. The role of interstitial fluid flow in the remodeling response to fatigue loading. J Bone Miner Res. 2002;17:2030-2037.

    Article  PubMed  CAS  Google Scholar 

  51. Epstein S. Is cortical bone hip? What determines cortical bone properties? Bone. 2007;41(1 Suppl 1):S3-S8.

    Article  PubMed  Google Scholar 

  52. Brown J, Prince R, Deal C, et al. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2010;25(5):983-993.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the technical teams in the Imaging, Histomorphometry, Biomechanics, and Immunochemistry laboratories at Charles River that made this work possible, and to Dr Luc Chouinard and Nancy Doyle for critical review of the manuscript.

Author information

Authors and Affiliations

  1. Department of Bone Research and General Toxicology, Charles River Preclinical Services, Montréal, Québec, Canada

    Susan Y. Smith

Authors
  1. Susan Y. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aurore Varela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacquelin Jolette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan Y. Smith .

Editor information

Editors and Affiliations

  1. Nepean Hospital, Dept. Geriatric Medicine, University of Sydney, Penrith, 2750, New South Wales, Australia

    Gustavo Duque

  2. Department of Bone & Joint Disease, National Center for Geriatrics & Geronto, Obu-Aichi, Japan

    Ken Watanabe

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Smith, S.Y., Varela, A., Jolette, J. (2011). Nonhuman Primate Models of Osteoporosis. In: Duque, G., Watanabe, K. (eds) Osteoporosis Research. Springer, London. https://doi.org/10.1007/978-0-85729-293-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-293-3_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-292-6

  • Online ISBN: 978-0-85729-293-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation